Trials / Unknown
UnknownNCT02859571
Continuous Versus Intermittent Oxytocin for Induction of Labor: A Randomized Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates continuous oxytocin versus intermittent oxytocin for induction of labor at term. Half of participants will be taken continuous oxytocin, while the other half will be taken intermittent oxytocin.
Detailed description
In the continuous oxytocin group, traditional treatment of oxytocin used at a starting dose of 1-2 mIU/min and the dose was increased by 2 mIU/min at every 15 minutes until regular contractions obtained at a rate of 3-5 contractions in a 10-minute period. The maximum dose of oxytocin was 40 mIU/min and oxytocin was administered until delivery. In the intermittent group, oxytocin was discontinued when cervical dilation was 5 cm and 2 hours after discontinuation oxytocin was reused at a starting dose of 1-2 mIU/min and was increased as the same protocol used for continuation oxytocin group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2016-12-01
- Completion
- 2017-01-01
- First posted
- 2016-08-09
- Last updated
- 2016-12-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02859571. Inclusion in this directory is not an endorsement.